Pharmaceuticals in Italy

Date: September 26, 2016
Pages: 31
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P336B5339F9EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Italy
SUMMARY

Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Italy
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Italy
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Italy pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Italy pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Italy pharmaceuticals market by value in 2015?
  • What will be the size of the Italy pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Italy pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Italy's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Italian pharmaceuticals market had total revenues of $24.0bn in 2015, representing a compound annual growth rate (CAGR) of 2.7% between 2011 and 2015.

Budgetary constraints are impacting the country's healthcare spend, and costly pharmaceuticals appear early on the list of things to be affected, something commonly seen throughout the European market.

The performance of the market is forecast to follow a similar pattern with an anticipated CAGR of 2.6% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $27.3bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Chiesi Farmaceutici S.p.A.
The Menarini Group
Pfizer Inc.
Recordati S.p.A.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Italy pharmaceuticals market value: $ billion, 2011-15
Table 2: Italy pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Italy pharmaceuticals market share: % share, by value, 2015
Table 4: Italy pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Chiesi Farmaceutici S.p.A.: key facts
Table 6: The Menarini Group: key facts
Table 7: Pfizer Inc.: key facts
Table 8: Pfizer Inc.: key financials ($)
Table 9: Pfizer Inc.: key financial ratios
Table 10: Recordati S.p.A.: key facts
Table 11: Italy size of population (million), 2011-15
Table 12: Italy gdp (constant 2005 prices, $ billion), 2011-15
Table 13: Italy gdp (current prices, $ billion), 2011-15
Table 14: Italy inflation, 2011-15
Table 15: Italy consumer price index (absolute), 2011-15
Table 16: Italy exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Italy pharmaceuticals market value: $ billion, 2011-15
Figure 2: Italy pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Italy pharmaceuticals market share: % share, by value, 2015
Figure 4: Italy pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Italy, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Italy, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Italy, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2015
Figure 11: Pfizer Inc.: revenues and profitability
Figure 12: Pfizer Inc.: assets and liabilities

COMPANIES MENTIONED

Chiesi Farmaceutici S.p.A.
The Menarini Group
Pfizer Inc.
Recordati S.p.A.
Skip to top


OTC Pharmaceuticals in Italy US$ 350.00 Sep, 2016 · 39 pages
The Pharmaceutical Market: Italy US$ 1,295.00 Jan, 2013 · 76 pages

Ask Your Question

Pharmaceuticals in Italy
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: